Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal

Cytotherapy

Volumn 6, Issue 4, 2004, Pages 328-336

  Young, Judy C ^a,b   Wu, S ^a   Hansteen, G ^a   Du, C ^a   Sambucetti, L ^a   Remiszewski, S ^a   O'Farrell, A M ^a   Hill, B ^a   Lavau, C ^a   Murray, L J ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b GENENTECH INC   (United States)

Author keywords

Hematopoietic stem cells; Histone deacetylase; Inhibitors; Non obese diabetic SCID mouse engraftment; Stem cell expansion

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD34 ANTIGEN; CHLAMYDOCIN; FLT3 LIGAND; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; TRAPOXIN; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL RENEWAL; CELL SUBPOPULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EX VIVO STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MODULATION; MOUSE; NONHUMAN; PHENOTYPE; STEM CELL MOBILIZATION; TRANSCRIPTION REGULATION; XENOTRANSPLANTATION;

EID: 4544275325     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240410004899     Document Type: Article

References (48)

1. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 1998;12:599-606.
2. Nagy L, Kao HY, Chakravarti D et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 1997;89:373-80.
3. Ayer DE, Lawrence QA, Eisenman RN. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 1995;80: 767-76.
4. Laherty CD, Yang WM, Sun JM et al. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 1997;89:349-56.
5. Lin RJ, Nagy L, Inoue S et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 1998;391:811-4.
6. Gelmetti V, Zhang J, Fanelli M et al. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 1998;18:7185-91.
7. Wang J, Hoshino T, Redner RL et al. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci USA 1998;95:10860-5.
8. Huang S, Brandt SJ. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol Cell Biol 2000;20:2248-59.
9. Kao H-Y, Ordentlich P, Koyano-Nakagawa N et al. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev 1998;12:2269-77.
10. van der Vlag J, Otte AP. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet 1999;23:474-8.
11. Saleh M, Rambaldi I, Yang XJ et al. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. Mol Cell Biol 2000;20:8623-33.
12. Chariot A, van Lint C, Chapelier M et al. CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene 1999;18:4007-14.
13. Reid A, Gould A, Brand N et al. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 1995;86:4544-52.
14. Yeyati PL, Shaknovich R, Boterashvili S et al. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 1999;18:925-34.
15. Karanu FN, Murdoch B, Gallacher L et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 2000;192:1365-72.
16. Varnum-Finney B, Xu L, Brashem-Stein C et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive notch1 signaling. Nat Med 2000;6:1278-81.
17. Thorsteinsdottir U, Sauvageau G, Humphries RK. Hox homeobox genes as regulators of normal and leukemic hematopoiesis. Hematol Oncol Clin North Am 1997;11:1221-37.
18. Sauvageau G, Thorsteinsdottir U, Eaves CJ et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 1995;9:1753-65.
19. Yoshida M, Kijima M, Akita M et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990;265:17174-9.
20. Kijima M, Yoshida M, Sugita K et al. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem 1993;268:22429-35.
21. Stahelin H, Trippmacher A. Cytostatic activity of chlamydocin, a rapidly inactivated cyclic tetrapeptide. Eur J Cancer 1974;10:801-8.
22. Brosch G, Ransom R, Lechner T et al. Inhibition of maize histone deacetylases by HC toxin, the host- selective toxin of Cochliobolus carbonum. Plant Cell 1995;7:1941-50.
23. Uchida N, Tsukamoto A, He D et al. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J Clin Invest 1998;101:961-6.
24. O'Farrell AM, Ichihara M, Mui AL et al. Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response. Blood 1996;87:3655-68.
25. O'Farrell AM, Parry DA, Zindy F et al. Stat3-dependent induction of p191NK4D by IL-10 contributes to inhibition of macrophage proliferation. J Immunol 2000;164:4607-15.
26. + cells into rapid division. Exp Hematol 1999;27:1019-28.
27. + subset following cell division ex vivo. Exp Hematol 1999;27:994-1003.
28. - cells with preserved ability to engraft SCID-hu bone. Blood 1998;91:1206-15.
29. Piacibello W, Sanavio F, Garetto L et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2644-53.
30. Piacibello W, Sanavio F, Garetto L et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia 1998;12:718-27.
31. - bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood 1997;90:2282-92.
32. Haylock DN, Horsfall MJ, Dowse TL et al. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood 1997;90:2260-72.
33. - primitive progenitor cells. Blood 1996;88:1619-31.
34. -) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-Kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha. J Immunol 1997;158:5169-77.
35. Young JC, Lin K, Wu S et al. Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokines. Cytotherapy 2001;3:307-20.
36. Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000;92:1210-6.
37. Richon VM, Sandhoff TW, Rifkind RA et al. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 2000;97:10014-9.
38. Purton LE, Bernstein ID, Collins SJ. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood 2000;95:470-7.
39. +)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors. Blood 1999; 94:483-95.
40. Vogelauer M, Wu J, Suka N et al. Global histone acetylation and deacetylation in yeast. Nature 2000;408:495-8.
41. Van Lint C, Emiliani S, Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 1996;5:245-53.
42. Spanopoulou E, Giguere V, Grosveld F. The functional domains of the murine Thy-1 gene promoter. Mol Cell Biol 1991;11:2216-28.
43. Doetzlhofer A, Rotheneder H, Lagger G et al. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol 1999;19:5504-11.
44. Hueber A-O, Bernard A-M, Langlet-El Battari C et al. Thymocytes in Thy-1 - / - mice show augmented TCR signaling and impaired differentiation. Curr Biol 1997;7: 705-8.
45. Mayani H, Lansdorp P. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994;83:2410-7.
46. Kiernan RE, Vanhulle C, Schiltz L et al. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J 1999;18:6106-18.
47. Martinez-Balbas MA, Bauer U-M, Nielsen SJ et al. Regulation of E2F1 activity by acetylation. EMBO J 2000;19:662.
48. Juan LJ, Shia WJ, Chen MH et al. Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem 2000;275:20436-43.